TotalMarketCap

NRX Pharmaceuticals

NRXPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$98.173 M

$2.27 -8.94%

Close of 6 Nov 2026

As of 6 Nov 2026, NRX Pharmaceuticals (NRXP) has a market capitalization of $98.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.23M

#3444 by revenue

Earnings

-$28.6M

Loss-making

Shares outstanding

43,295,767

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #291CellectisCLLS$101.5M
  2. #292ImmunicIMUX$101.0M
  3. #293NRX PharmaceuticalsNRXP$98.2M
  4. #294PMV PharmaceuticalsPMVP$96.7M
  5. #295Unicycive TherapeuticsUNCY$96.7M

What if NRX Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$652,185.55

Per share 287,623× higher

Bitcoin $1.53T

$35,288.62

Per share 15,563× higher

Apple $5.02T

$115,849.26

Per share 51,091× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for NRX Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.